Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Evoke Pharma Inc. buy Maxi_Scalibusa

Start price
€28.25
21.01.21 / 50%
Target price
€120.00
21.01.23
Performance (%)
-86.83%
End price
€3.72
21.01.23
Summary
This prediction ended on 21.01.23 with a price of €3.72. The BUY prediction by Maxi_Scalibusa for Evoke Pharma Inc. performed very badly with a performance of -86.83%. Maxi_Scalibusa has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Evoke Pharma Inc. -14.468% -14.468% -76.897% -97.504%
iShares Core DAX® 1.051% -1.833% 12.822% 15.392%
iShares Nasdaq 100 -0.547% -3.738% 40.625% 42.396%
iShares Nikkei 225® -1.778% -8.115% 16.092% 0.891%
iShares S&P 500 0.002% -2.226% 28.387% 41.095%

According to Maxi_Scalibusa what are the pros and cons of Evoke Pharma Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by Maxi_Scalibusa for this prediction

In the thread Evoke Pharma Inc. diskutieren
Prediction Buy
Perf. (%) -86.83%
Target price 10.000
Change
Ends at 21.01.23

Buy mit Kursziel 10,0

In the thread Trading Evoke Pharma Inc.
Prediction Buy
Perf. (%) -86.83%
Target price 120.000
Change
Ends at 21.01.23

Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten